Andrew W Keegan - Academia.edu (original) (raw)

Andrew W Keegan

Alexander Morrison related author profile picture

Lauren Hall-Lew related author profile picture

Remo Caponi related author profile picture

Armando Marques-Guedes related author profile picture

Emrah Safa Gürkan (ESG) related author profile picture

Martin O'Neill related author profile picture

Hacer Topaktas Ustuner related author profile picture

Stéphane Péquignot related author profile picture

Yasemin Bayyurt related author profile picture

Nicola Lupo related author profile picture

Uploads

Papers by Andrew W Keegan

Research paper thumbnail of Cross validation of the Montreal Cognitive Assessment in community dwelling older adults residing in the Southeastern US

International Journal of Geriatric Psychiatry, 2009

Objective Cross validation study of the MoCA for the detection of Alzheimer's disease (AD) and Mi... more Objective Cross validation study of the MoCA for the detection of Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) in a community-based cohort residing in the Southeastern United States. Methods One hundred and eighteen English-speaking older adults, who underwent diagnostic evaluation as part of an ongoing prospective study, were administered the MoCA and MMSE. Twenty were diagnosed with AD, 24 met criteria for amnestic MCI and 74 were considered cognitively normal. Sensitivities and specificities were calculated using the recommended cutoff scores and ROC curve analyses were performed to determine optimal sensitivity and specificity. The influence of age, education and gender on MoCA score was also examined. Results Using a cutoff score of 24 or below, the MMSE was insensitive to cognitive impairment. Using the recommended cutoff score of 26, the MoCA detected 97% of those with cognitive impairment but specificity was fair (35%). Using a lower cutoff score of 23, the MoCA exhibited excellent sensitivity (96%) and specificity (95%). Conclusion The MoCA appears to have utility as a cognitive screen for early detection of AD and for MCI and warrants further investigation regarding its applicability in primary care settings, varying ethnic groups, and younger at-risk individuals.

Research paper thumbnail of Cross validation of the Montreal Cognitive Assessment in community dwelling older adults residing in the Southeastern US

International Journal of Geriatric Psychiatry, 2009

Objective Cross validation study of the MoCA for the detection of Alzheimer's disease (AD) and Mi... more Objective Cross validation study of the MoCA for the detection of Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) in a community-based cohort residing in the Southeastern United States. Methods One hundred and eighteen English-speaking older adults, who underwent diagnostic evaluation as part of an ongoing prospective study, were administered the MoCA and MMSE. Twenty were diagnosed with AD, 24 met criteria for amnestic MCI and 74 were considered cognitively normal. Sensitivities and specificities were calculated using the recommended cutoff scores and ROC curve analyses were performed to determine optimal sensitivity and specificity. The influence of age, education and gender on MoCA score was also examined. Results Using a cutoff score of 24 or below, the MMSE was insensitive to cognitive impairment. Using the recommended cutoff score of 26, the MoCA detected 97% of those with cognitive impairment but specificity was fair (35%). Using a lower cutoff score of 23, the MoCA exhibited excellent sensitivity (96%) and specificity (95%). Conclusion The MoCA appears to have utility as a cognitive screen for early detection of AD and for MCI and warrants further investigation regarding its applicability in primary care settings, varying ethnic groups, and younger at-risk individuals.

Log In